SCHEMBL1509799

SCHEMBL1509799

COc1cc2cccnc2c2c1C(=O)C(C(=O)O)C=N2.O=C(O)C1C=Nc2c(c(O)cc3cccnc23)C1=O

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC40A1 Q9NP59 1/20 0.37
L3MBTL1 Q9Y468 5/20 0.37
RAB9A P51151 5/20 0.37
KDM4E B2RXH2 4/20 0.37
LMNA P02545 4/20 0.37
HTT P42858 3/20 0.37
TP53 P04637 3/20 0.37
MITF O75030 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
NPC1 O15118 2/20 0.37
MEN1 O00255 4/20 0.36
KMT2A Q03164 4/20 0.36
RELA Q04206 2/20 0.36
NFKBIA P25963 1/20 0.36
MAPK1 P28482 2/20 0.35
TDP1 Q9NUW8 2/20 0.35
NFKB1 P19838 1/20 0.35
NFKB2 Q00653 1/20 0.35
PDGFRB P09619 1/20 0.34
PDGFRA P16234 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL965521 0.95 SLC40A1 (0.40) SLC40A1L3MBTL1RAB9AKDM4ELMNA
SCHEMBL967454 0.90 L3MBTL1 (0.39) L3MBTL1RAB9AKDM4ELMNAHTT
SCHEMBL6985519 0.82 RELA (0.38) SLC40A1L3MBTL1RAB9AKDM4ELMNA
SCHEMBL6987201 0.80 CCR1 (0.40) SLC40A1L3MBTL1RAB9AKDM4ELMNA
SCHEMBL6975182 0.78 L3MBTL1 (0.40) SLC40A1L3MBTL1MEN1KMT2AALDH1A1
SCHEMBL5819956 0.72 DAO (0.36) L3MBTL1RAB9AKDM4ELMNANPC1
SCHEMBL6978820 0.71 KDM4E (0.37) L3MBTL1RAB9AKDM4ELMNAHTT
SCHEMBL6985131 0.71 KDM4E (0.37) L3MBTL1RAB9AKDM4ELMNAHTT
SCHEMBL1509598 0.70 LMNA (0.43) SLC40A1L3MBTL1KDM4ELMNAHTT
SCHEMBL6984797 0.68 MAPK1 (0.38) L3MBTL1RAB9AKDM4ELMNAHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2298301-A2 Medicaments for increasing endogenous Erythropoietin (EPO) Fibrogen, Inc. (US) 2011-03-23 EP disclosed